Cediranib (C007B-081110)

Catalog No.: C007B-081110
Manufacturer No.: C125911-10mg
Manufacturer Name: Aladdin Scientific
Quantity: 1
Unit of Measure: EA

Cediranib (AZD2171) is a highly potent VEGFR(KDR) inhibitor with IC50 of <:1 nM, also inhibits Flt1/4 with IC50 of 5 nM/≤3 nM, similar activity against c-Kit and PDGFRβ, 36-, 110-fold and >:1000-fold selective more for VEGFR than PDGFR-α, CSF-1R

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Description
Specifications

Cediranib (AZD2171) is a highly potent VEGFR(KDR) inhibitor with IC50 of <1 nM, also inhibits Flt1/4 with IC50 of 5 nM/≤3 nM, similar activity against c-Kit and PDGFRβ, 36-, 110-fold and >1000-fold selective more for VEGFR than PDGFR-α, CSF-1R and Flt3, Phase 3.

Specifications and Purity: ≥98%

Molecular Formula: C25H27FN4O3

Molecular Weight: 450.52

PubChem CID: 9933475

Isomeric SMILES: CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5

Related Documents: https://aladdin-for-icloud-store.oss-cn-hangzhou.aliyuncs.com/aladdinsci/pdp/sds/1/C125911-SCI_4e89510b05b613869f01babaf8b54e3b.pdf

UPC:: 51111606
Condition:: New
HazmatClass:: Yes
WeightUOM:: LB
MPN:: C125911-10mg
CAS:: 288383-20-0
Health Hazards:: Toxic
Product Size:: 10mg
Hazard Statement Codes:: H312:H301
Precautionary Statement Codes:: P501:P405:P362+P364:P302+P352:P391:P330:P280:P273:P270:P264:P260

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."